UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Syphilis in pregnancy

Authors
Errol R Norwitz, MD, PhD, MBA
Charles B Hicks, MD
Section Editors
Charles J Lockwood, MD, MHCM
Noreen A Hynes, MD, MPH, DTM&H
Deputy Editors
Vanessa A Barss, MD, FACOG
Jennifer Mitty, MD, MPH

INTRODUCTION

Syphilis is a systemic infection caused by the spirochete Treponema pallidum, which is of particular concern during pregnancy because of the risk of transplacental infection of the fetus. Congenital infection can be associated with several adverse outcomes, including perinatal death.

Issues related to syphilis during pregnancy will be reviewed here. Syphilis in children and nonpregnant adults are discussed separately. (See "Congenital syphilis: Clinical features and diagnosis" and "Congenital syphilis: Evaluation, management, and prevention" and "Syphilis: Epidemiology, pathophysiology, and clinical manifestations in HIV-uninfected patients" and "Syphilis: Treatment and monitoring".)

INCIDENCE

In the United States, the rate of primary and secondary syphilis in women increased from 1.1 cases per 100,000 females in 2014 to 1.4 cases per 100,000 females in 2015 to 1.9 cases in 2016 [1], a 35.7 percent increase in the last year of reporting. Increases in syphilis among women is often followed by increases in congenital syphilis cases as most cases are in reproductive-aged women.

After a steady decline, the rate of congenital syphilis has also increased 86.9 percent between 2012 and 2016, with 15.7 cases per 100,000 live births reported in 2016. Congenital syphilis rates (cases per 100,000 live births) among infants by maternal race/ethnicity were: black (43.1), American Indian/Alaska Native (31.6), Hispanic (20.5), Asian/Pacific Islander (9.2), and white (5.3).

EPIDEMIOLOGY

Syphilis occurs with equal frequency in men and women worldwide [2], but men are more commonly infected in the United States. It is more common among pregnant women who are poor, young (age <29 years), African American, and lack health insurance and prenatal care. Other risk factors include use of illicit drugs, infection with other sexually transmitted diseases, residence in an area of high syphilis prevalence, and being a sex worker [3,4].

                                               
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Dec 06, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. United States Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2016. https://www.cdc.gov/std/stats16/Syphilis.htm (Accessed on October 05, 2017).
  2. Newman L, Rowley J, Vander Hoorn S, et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One 2015; 10:e0143304.
  3. U.S. Preventive Services Task Force. Screening for syphilis infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2009; 150:705.
  4. Rac MW, Revell PA, Eppes CS. Syphilis during pregnancy: a preventable threat to maternal-fetal health. Am J Obstet Gynecol 2017; 216:352.
  5. ROCKWELL DH, YOBS AR, MOORE MB Jr. THE TUSKEGEE STUDY OF UNTREATED SYPHILIS; THE 30TH YEAR OF OBSERVATION. Arch Intern Med 1964; 114:792.
  6. Sparling PF. Natural history of syphilis. In: Sexually Transmitted Diseases, Holmes KK, Mardh PA, Sparling PF, et al (Eds), McGraw-Hill, New York 1990. p.213.
  7. Newman L, Kamb M, Hawkes S, et al. Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Med 2013; 10:e1001396.
  8. Cheng JQ, Zhou H, Hong FC, et al. Syphilis screening and intervention in 500,000 pregnant women in Shenzhen, the People's Republic of China. Sex Transm Infect 2007; 83:347.
  9. Royal College of Obstetricians and Gynaecologists. National evidence-based clinical guidelines. Antenatal care: Routine care for the healthy pregnant woman. www.rcog.org.uk/index.asp?PageID=693 (Accessed on March 28, 2006).
  10. Hossain M, Broutet N, Hawkes S. The elimination of congenital syphilis: a comparison of the proposed World Health Organization action plan for the elimination of congenital syphilis with existing national maternal and congenital syphilis policies. Sex Transm Dis 2007; 34:S22.
  11. Wolff T, Shelton E, Sessions C, Miller T. Screening for syphilis infection in pregnant women: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2009; 150:710.
  12. Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.
  13. American Academy of Pediatrics Committee on Fetus and Newborn and Amercian College of Obstetricians and Gynecologists Committee on Obstetric Practice. Guidelines for Perinatal Care, 8th, Kilpatrick SJ, Papile L (Eds), 2017.
  14. Geusau A, Kittler H, Hein U, et al. Biological false-positive tests comprise a high proportion of Venereal Disease Research Laboratory reactions in an analysis of 300,000 sera. Int J STD AIDS 2005; 16:722.
  15. Tinajeros F, Grossman D, Richmond K, et al. Diagnostic accuracy of a point-of-care syphilis test when used among pregnant women in Bolivia. Sex Transm Infect 2006; 82 Suppl 5:v17.
  16. Albright CM, Emerson JB, Werner EF, Hughes BL. Third-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness Analysis. Obstet Gynecol 2015; 126:479.
  17. Rogozińska E, Kara-Newton L, Zamora JR, Khan KS. On-site test to detect syphilis in pregnancy: a systematic review of test accuracy studies. BJOG 2017; 124:734.
  18. ACOG Committee on Obstetric Practice. ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol 2004; 104:1119.
  19. Ray JG. Lues-lues: maternal and fetal considerations of syphilis. Obstet Gynecol Surv 1995; 50:845.
  20. Woolston S, Cohen SE, Fanfair RN, et al. A Cluster of Ocular Syphilis Cases - Seattle, Washington, and San Francisco, California, 2014-2015. MMWR Morb Mortal Wkly Rep 2015; 64:1150.
  21. Wendel GD Jr, Sheffield JS, Hollier LM, et al. Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis 2002; 35:S200.
  22. Zhu L, Qin M, Du L, et al. Maternal and congenital syphilis in Shanghai, China, 2002 to 2006. Int J Infect Dis 2010; 14 Suppl 3:e45.
  23. Hawkes S, Matin N, Broutet N, Low N. Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis. Lancet Infect Dis 2011; 11:684.
  24. Nathan L, Bawdon RE, Sidawi JE, et al. Penicillin levels following the administration of benzathine penicillin G in pregnancy. Obstet Gynecol 1993; 82:338.
  25. Weeks JW, Myers SR, Lasher L, et al. Persistence of penicillin G benzathine in pregnant group B streptococcus carriers. Obstet Gynecol 1997; 90:240.
  26. Wendel GD Jr, Stark BJ, Jamison RB, et al. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985; 312:1229.
  27. World Health Organization. Guidelines for treatment of Treponema pallidum (syphilis). http://apps.who.int/iris/bitstream/10665/249572/1/9789241549806-eng.pdf?ua=1 (Accessed on September 15, 2016).
  28. Zhou P, Gu Z, Xu J, et al. A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy. Sex Transm Dis 2005; 32:495.
  29. Klein VR, Cox SM, Mitchell MD, Wendel GD Jr. The Jarisch-Herxheimer reaction complicating syphilotherapy in pregnancy. Obstet Gynecol 1990; 75:375.
  30. Myles TD, Elam G, Park-Hwang E, Nguyen T. The Jarisch-Herxheimer reaction and fetal monitoring changes in pregnant women treated for syphilis. Obstet Gynecol 1998; 92:859.
  31. Fekade D, Knox K, Hussein K, et al. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med 1996; 335:311.
  32. Coxon RE, Fekade D, Knox K, et al. The effect of antibody against TNF alpha on cytokine response in Jarisch-Herxheimer reactions of louse-borne relapsing fever. QJM 1997; 90:213.
  33. Gudjónsson H, Skog E. The effect of prednisolone on the Jarisch-Herxheimer reaction. Acta Derm Venereol 1968; 48:15.
  34. Pound MW, May DB. Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions. J Clin Pharm Ther 2005; 30:291.
  35. Remick DG, Negussie Y, Fekade D, Griffin G. Pentoxifylline fails to prevent the Jarisch-Herxheimer reaction or associated cytokine release. J Infect Dis 1996; 174:627.
  36. FIUMARA NJ, FLEMING WL, DOWNING JG, GOOD FL. The incidence of prenatal syphilis at the Boston City Hospital. N Engl J Med 1952; 247:48.
  37. Ricci JM, Fojaco RM, O'Sullivan MJ. Congenital syphilis: the University of Miami/Jackson Memorial Medical Center experience, 1986-1988. Obstet Gynecol 1989; 74:687.
  38. FIUMARA NJ. Congenital syphilis in Massachusetts. N Engl J Med 1951; 245:634.
  39. Giakoumelou S, Wheelhouse N, Cuschieri K, et al. The role of infection in miscarriage. Hum Reprod Update 2016; 22:116.
  40. Lago EG, Vaccari A, Fiori RM. Clinical features and follow-up of congenital syphilis. Sex Transm Dis 2013; 40:85.
  41. Mascola L, Pelosi R, Blount JH, et al. Congenital syphilis. Why is it still occurring? JAMA 1984; 252:1719.
  42. Harter C, Benirschke K. Fetal syphilis in the first trimester. Am J Obstet Gynecol 1976; 124:705.
  43. Hollier LM, Harstad TW, Sanchez PJ, et al. Fetal syphilis: clinical and laboratory characteristics. Obstet Gynecol 2001; 97:947.
  44. Gomez GB, Kamb ML, Newman LM, et al. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ 2013; 91:217.
  45. Qin J, Yang T, Xiao S, et al. Reported estimates of adverse pregnancy outcomes among women with and without syphilis: a systematic review and meta-analysis. PLoS One 2014; 9:e102203.
  46. Harman NB. Staying the Plague, Methuen & Co., LTD, London 1917.
  47. INGRAHAM NR Jr. The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Derm Venereol Suppl (Stockh) 1950; 31:60.
  48. Sheffield JS, Sánchez PJ, Morris G, et al. Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol 2002; 186:569.
  49. Fiumara NJ. Syphilis in newborn children. Clin Obstet Gynecol 1975; 18:183.
  50. Rac MW, Bryant SN, McIntire DD, et al. Progression of ultrasound findings of fetal syphilis after maternal treatment. Am J Obstet Gynecol 2014; 211:426.e1.
Topic Outline

GRAPHICS